Pharming Group NV (PHAR)

0.830
-0.004(-0.43%)
  • Volume:
    1,236,758
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.827 - 0.839

PHAR Overview

Prev. Close
0.833
Day's Range
0.827-0.839
Revenue
174.4M
Open
0.839
52 wk Range
0.79-1.5
EPS
0.04
Volume
1,236,758
Market Cap
538.35M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,954,680
P/E Ratio
20.23
Beta
1.56
1-Year Change
-9.4%
Shares Outstanding
646,123,246
Next Earnings Date
Oct. 28, 2021
What is your sentiment on Pharming Group NV?
or
Vote to see community's results!

Pharming Group NV News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuyStrong SellStrong Sell
Technical IndicatorsNeutralBuyBuySellStrong Sell
SummaryBuyBuyBuyStrong SellStrong Sell

Pharming Group NV Company Profile

Pharming Group NV Company Profile

Employees
262

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.